A young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy trial has died, the pharma shared in a May 7 Read this story
A young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy trial has died, the pharma shared in a May 7 Read this story
More from Fierce Biotech | Pfizer Cell & Gene Therapy Duchenne muscular dystrophy gene therapy Sarepta patient death Biotech Fierce Biotech Homepage Gene therapy